866-997-4948(US-Canada Toll Free)

Hidradenitis Suppurativa Global Clinical Trials Review, H1, 2012

Published By :

GlobalData

Published Date : May 2012

Category :

Clinical Trials

No. of Pages : 103 Pages



GlobalData's clinical trial report, Hidradenitis Suppurativa Global Clinical Trials Review, H1, 2012" provides data on the Hidradenitis Suppurativa clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Hidradenitis Suppurativa . It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Hidradenitis Suppurativa . This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations 
  • Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
  • Listings of discontinued trials (suspended, withdrawn and terminated)
Reasons to buy

  • Understand the dynamics of a particular indication in a condensed manner
  • Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
  • Obtain discontinued trial listing for trials across the globe
  • Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies
Keywords

Hidradenitis Suppurativa Clinical Trials, Trial Designs, Subjects Recruited, Unaccomplished Trials of Hidradenitis Suppurativa , Pfizer, AstraZeneca, Novartis, GlaxoSmithKline, Sanofi, Eli Lilly and Company, Johnson & Johnson, Merck & Co., Inc, Bristol-Myers Squibb Company, Abbott Laboratories, Hoffmann-La Roche Ltd., Celgene Corporation, Daiichi Sankyo Company, Ltd., Bayer AG, Eisai Inc., GE Healthcare, Biogen Idec Inc., Copharos Inc., Wyeth Pharmaceuticals Inc., National Cancer Center, The University of Texas, M.D. Andersons, Vanderbilt Medical Center, Memorial Sloan Kettering Cancer Center, Cancer Research UK, North Central Cancer Group, Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Fred Hutchinson Cancer Research Center, European Organization for Research and Treatment of Cancer, Dana-Farber Cancer Institute, The Cancer and Leukemia Group B, Columbia University, UCLA's Jonsson Comprehensive Cancer Center, Case Comprehensive Cancer Center, Mayo Clinic, Duke University, Ohio State University, National Cancer Center, University of Pennsylvania.
Table of Contents

Table of Contents 2
List of Tables 3
List of Figures 4

Introduction 5
Hidradenitis Suppurativa 5
Report Guidance 5
Clinical Trials by Region 6
Clinical Trials by Country 7
Top Countries Contributing to Clinical Trials in Asia-Pacific 9
Top Five Countries Contributing to Clinical Trials in Europe 10
Top Countries Contributing to Clinical Trials in North America 11
Top Countries Contributing to Clinical Trials in Central and South America 12
Clinical Trials by G7 Nations 13
Clinical Trials in G7 Nations by Trial Status 14
Clinical Trials by Phase 15
In Progress Trials by Phase 16
Clinical Trials by Trial Status 17
Unaccomplished Trials of Hidradenitis Suppurativa 18
Subjects Recruited Over a Period of Time 19
Prominent Sponsors 20
Top Companies Participating in Hidradenitis Suppurativa Therapeutics Clinical Trials 22
Prominent Drug Comparison 23
Clinical Trial Profiles 24
Clinical Trial Overview of Top Companies 24
Abbott Laboratories 24
Clinical Trial Overview of Abbott Laboratories 24
Laboratoire Labcatal 25
Clinical Trial Overview of Laboratoire Labcatal 25
Clinical Trial Overview of Top Universities / Institutes / Hospitals 26
University of Athens 26
Clinical Trial Overview of University of Athens 26
Henry Ford Health System 27
Clinical Trial Overview of Henry Ford Health System 27
Florida Academic Dermatology Centers 28
Clinical Trial Overview of Florida Academic Dermatology Centers 28
The University of Kansas 29
Clinical Trial Overview of The University of Kansas 29
Erasmus MC 30
Clinical Trial Overview of Erasmus MC 30
New York University School of Medicine 31
Clinical Trial Overview of New York University School of Medicine 31
University of Pennsylvania 32
Clinical Trial Overview of University of Pennsylvania 32
Penn State University 33
Clinical Trial Overview of Penn State University 33
Massachusetts General Hospital 34
Clinical Trial Overview of Massachusetts General Hospital 34
University of California, San Francisco 35
Clinical Trial Overview of University of California, San Francisco 35
Five Key Clinical Profiles 36

Appendix 100
Abbreviations 100
Definitions 100
Research Methodology 101
Secondary Research 101
About GlobalData 102
Contact Us 102
Disclaimer 102
Source 103

List of Table

 
Hidradenitis Suppurativa Therapeutics Market, Global, Clinical Trials by Zone, 2012* 6
Hidradenitis Suppurativa Therapeutics Market, Global, Clinical Trials by Top Countries, 2012* 7
Hidradenitis Suppurativa Therapeutics Market, Global, Clinical Trials In Progress by Top Countries, 2012* 8
Hidradenitis Suppurativa Therapeutics Clinical Trials, Asia-Pacific, Top Countries, 2012* 9
Hidradenitis Suppurativa Therapeutics Clinical Trials, Europe, Top Five Countries, 2012* 10
Hidradenitis Suppurativa Therapeutics Clinical Trials, North America, Top Countries, 2012* 11
Hidradenitis Suppurativa Therapeutics Clinical Trials, Central and South America, Top Countries, 2012* 12
Hidradenitis Suppurativa Therapeutics Clinical Trials, G7 Countries, 2012* 13
Hidradenitis Suppurativa Therapeutics Market, G7 Countries, Clinical Trials by Trial Status, 2012* 14
Hidradenitis Suppurativa Therapeutics Market, Global, Clinical Trials by Phase, 2012* 15
Hidradenitis Suppurativa Therapeutics Market, Global, Clinical Trials In Progress by Phase 2012* 16
Hidradenitis Suppurativa Therapeutics Market, Global, Clinical Trials by Trial Status, 2012* 17
Hidradenitis Suppurativa Therapeutics Market, Global, Terminated Clinical Trials, 2012* 18
Hidradenitis Suppurativa Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2005-2010 19
Hidradenitis Suppurativa Therapeutics Clinical Trials, Global, Key Sponsors, 2012* 21
Hidradenitis Suppurativa Therapeutics Clinical Trials, Global, Top Companies by Phase, 2012* 22
Hidradenitis Suppurativa Therapeutics Clinical Trials, Global, Clinical Trials by Prominent Drugs, 2012* 23
Hidradenitis Suppurativa Therapeutics Clinical Trials Market, Global, Clinical Trials by Abbott Laboratories, 2012* 24
Hidradenitis Suppurativa Therapeutics Clinical Trials Market, Global, Clinical Trials by Laboratoire Labcatal, 2012* 25
Hidradenitis Suppurativa Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Athens, 2012* 26
Hidradenitis Suppurativa Therapeutics Clinical Trials Market, Global, Clinical Trials by Henry Ford Health System, 2012* 27
Hidradenitis Suppurativa Therapeutics Clinical Trials Market, Global, Clinical Trials by Florida Academic Dermatology Centers, 2012* 28
Hidradenitis Suppurativa Therapeutics Clinical Trials Market, Global, Clinical Trials by The University of Kansas, 2012* 29
Hidradenitis Suppurativa Therapeutics Clinical Trials Market, Global, Clinical Trials by Erasmus MC, 2012* 30
Hidradenitis Suppurativa Therapeutics Clinical Trials Market, Global, Clinical Trials by New York University School of Medicine, 2012* 31
Hidradenitis Suppurativa Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Pennsylvania, 2012* 32
Hidradenitis Suppurativa Therapeutics Clinical Trials Market, Global, Clinical Trials by Penn State University, 2012* 33
Hidradenitis Suppurativa Therapeutics Clinical Trials Market, Global, Clinical Trials by Massachusetts General Hospital, 2012* 34
Hidradenitis Suppurativa Therapeutics Clinical Trials Market, Global, Clinical Trials by University of California, San Francisco, 2012* 35

List of Chart

List of Figures

Hidradenitis Suppurativa Therapeutics Market, Global, Clinical Trials by Zone (%), 2012* 6
Hidradenitis Suppurativa Therapeutics Market, Global, Clinical Trials by Top Countries, 2012* 7
Hidradenitis Suppurativa Therapeutics Market, Global, Clinical Trials In Progress by Top Countries, 2012* 8
Hidradenitis Suppurativa Therapeutics Clinical Trials, Asia-Pacific, Top Countries (%), 2012* 9
Hidradenitis Suppurativa Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2012* 10
Hidradenitis Suppurativa Therapeutics Clinical Trials, North America, Top Countries (%), 2012* 11
Hidradenitis Suppurativa Therapeutics Clinical Trials, Central and South America, Top Countries (%), 2012* 12
Hidradenitis Suppurativa Therapeutics Clinical Trials, G7 Countries (%), 2012* 13
Hidradenitis Suppurativa Therapeutics Market, G7 Countries, Clinical Trials by Trial Status, 2012* 14
Hidradenitis Suppurativa Therapeutics Market, Global, Clinical Trials by Phase (%), 2012* 15
Hidradenitis Suppurativa Therapeutics Market, Global, Clinical Trials In Progress by Phase, 2012* 16
Hidradenitis Suppurativa Therapeutics Market, Global, Clinical Trials by Trial Status, 2012* 17
Hidradenitis Suppurativa Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2005-2010 19
Hidradenitis Suppurativa Therapeutics Clinical Trials, Global, Key Sponsors, 2012* 20
Hidradenitis Suppurativa Therapeutics Clinical Trials, Global, Top Companies by Phase, 2012* 22
Hidradenitis Suppurativa Therapeutics Clinical Trials, Global, Clinical Trials by Prominent Drugs, 2012* 23
GlobalData Methodology 101

Make an enquiry before buying this Report

Please fill the enquiry form below.

  • Full Name *
  • Your Email *
  • Job Title
  • Company
  • Phone No. * (Pls. Affix Country Code)
  • Message
  • Security Code *